---
title: "GILEAD SCIENCES, INC. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/601e55e5-ff7d-5603-a86e-1f1ee799a384
json: https://whiteintel.dev/api/public/dossier/601e55e5-ff7d-5603-a86e-1f1ee799a384
identifier: sec:0000882095
jurisdiction: US
risk: High
source: WhiteIntel corporate-ownership graph
---

# GILEAD SCIENCES, INC.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0000882095`  
**Risk level:** High  
**Canonical dossier:** https://whiteintel.dev/entity/601e55e5-ff7d-5603-a86e-1f1ee799a384  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/601e55e5-ff7d-5603-a86e-1f1ee799a384  

## Ownership & control

### Holdings / subsidiaries

- **Arcus Biosciences, Inc.** (10% owner) — https://whiteintel.dev/entity/34c06870-0cbd-5e8c-b738-757e68d38db4
- **ASSEMBLY BIOSCIENCES, INC.** (tenpercentowner) — https://whiteintel.dev/entity/ce9d28ef-8333-5675-a262-2619d01f6ef6
- **Xilio Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/985ac0f2-bc6f-5a09-a727-79dcd06514ef
- **Arcus Biosciences, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/34c06870-0cbd-5e8c-b738-757e68d38db4
- **CYPHERPUNK TECHNOLOGIES INC.** (tenpercentowner) — https://whiteintel.dev/entity/e006b3dc-312e-5394-90e8-a34600f4dfc0
- **Kyverna Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/f0d67aac-4707-507f-88b3-33747c372407
- **Arcellx, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/e625d136-debd-5008-ae56-bd94b2ad17ab
- **HOOKIPA PHARMA INC.** (tenpercentowner) — https://whiteintel.dev/entity/6eec1b59-cf72-5b96-9bd0-17f03bf1eacf
- **Kalaris Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
- **JOUNCE THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/779ae22f-db7f-5a1a-94bd-bee3b2ea0147
- **ACHILLION PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/a4d7c988-81e6-53c4-957e-0d88456b3bee

### UBO chain (walk to the ultimate owner)

A **73-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GILEAD SCIENCES, INC.** — https://whiteintel.dev/entity/601e55e5-ff7d-5603-a86e-1f1ee799a384 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GILEAD SCIENCES, INC.**. Human view: https://whiteintel.dev/entity/601e55e5-ff7d-5603-a86e-1f1ee799a384 · Structured JSON: https://whiteintel.dev/api/public/dossier/601e55e5-ff7d-5603-a86e-1f1ee799a384._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._